{"id":"https://openalex.org/W4362477832","doi":"https://doi.org/10.1158/1535-7163.c.6535977","title":"Data from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth","display_name":"Data from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477832","doi":"https://doi.org/10.1158/1535-7163.c.6535977"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6535977","doi":"https://doi.org/10.1158/1535-7163.c.6535977","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6535977","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6535977","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106615740","display_name":"Marc A. Becker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc A. Becker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008282923","display_name":"Thahir Farzan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thahir Farzan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102960136","display_name":"Sean C. Harrington","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean C. Harrington","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067871955","display_name":"James Walter Krempski","orcid":"https://orcid.org/0000-0003-4901-5791","observed_orcids":["https://orcid.org/0000-0003-4901-5791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James W. Krempski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008232098","display_name":"S. John Weroha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. John Weroha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112318039","display_name":"Xiaonan Hou","orcid":"https://orcid.org/0000-0002-9406-4747","observed_orcids":["https://orcid.org/0000-0002-9406-4747"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaonan Hou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065524254","display_name":"Kimberly R. Kalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly R. Kalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110277","display_name":"Tai Wai Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tai W. Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089153267","display_name":"Paul Haluska","orcid":"https://orcid.org/0000-0003-3283-4512","observed_orcids":["https://orcid.org/0000-0003-3283-4512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Haluska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vegf-receptor-inhibition","display_name":"VEGF receptor inhibition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/dual-receptor-targeting","display_name":"dual receptor targeting","score":0.5870000123977661},{"id":"https://openalex.org/keywords/cediranib","display_name":"cediranib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pan-her-inhibitor","display_name":"pan-HER inhibitor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.781000018119812},{"id":"https://openalex.org/keywords/growth-factor-signaling","display_name":"growth factor signaling","score":0.8389999866485596},{"id":"https://openalex.org/keywords/serous-ovarian-cancer","display_name":"serous ovarian cancer","score":0.9399999976158142},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8193877935409546},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6434824466705322},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5322040915489197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49890685081481934},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.497592955827713},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.48964911699295044},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.45943066477775574},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.45911094546318054},{"id":"https://openalex.org/C2780084626","wikidata":"https://www.wikidata.org/wiki/Q11793790","display_name":"Ovarian tumor","level":4,"score":0.4197831451892853},{"id":"https://openalex.org/C2778324911","wikidata":"https://www.wikidata.org/wiki/Q9631","display_name":"Ovary","level":2,"score":0.41435861587524414},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36068013310432434},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32713782787323},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6535977","doi":"https://doi.org/10.1158/1535-7163.c.6535977","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6535977","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6535977","doi":"https://doi.org/10.1158/1535-7163.c.6535977","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6535977","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8399999737739563,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2122074718","https://openalex.org/W2070509111","https://openalex.org/W4392158917","https://openalex.org/W2022130531","https://openalex.org/W2169803229","https://openalex.org/W2524917620","https://openalex.org/W2020489786","https://openalex.org/W2079262408","https://openalex.org/W4362492923","https://openalex.org/W2902825151"],"abstract_inverted_index":{"Abstract":[0],"Ovarian":[1],"cancer":[2,90,174,197],"mortality":[3],"ranks":[4],"highest":[5],"among":[6],"all":[7],"gynecologic":[8],"cancers":[9],"with":[10,147,187],"growth":[11,155],"factor":[12,156],"pathways":[13,50],"playing":[14],"an":[15],"integral":[16],"role":[17],"in":[18,37,67,94,100,125,191],"tumorigenesis,":[19],"metastatic":[20],"dissemination,":[21],"and":[22,27,77,123,133,166],"therapeutic":[23],"resistance.":[24],"The":[25],"HER":[26,47,76,165],"VEGF":[28,49],"receptor":[29],"(VEGFR)":[30],"are":[31],"both":[32,121],"overexpressed":[33],"and/or":[34],"aberrantly":[35],"activated":[36],"subsets":[38,171],"of":[39,57,127,164,172],"ovarian":[40,68,89,173,196],"tumors.":[41,175,199],"While":[42],"agents":[43,59],"targeting":[44],"either":[45],"the":[46,55,72,150],"or":[48,111],"alone":[51],"have":[52,60],"been":[53],"investigated,":[54],"impact":[56],"these":[58],"not":[61],"led":[62],"to":[63,102,120],"overall":[64,152,189],"survival":[65,190],"benefit":[66,169],"cancer.":[69],"We":[70],"tested":[71,99],"hypothesis":[73],"that":[74,161,185],"cotargeting":[75],"VEGFR":[78,167],"would":[79],"maximize":[80],"antitumor":[81],"efficacy":[82],"at":[83],"tolerable":[84],"doses.":[85],"To":[86,176],"this":[87,177],"end,":[88,178],"xenografts":[91],"grown":[92],"intraperitoneally":[93],"athymic":[95],"nude":[96],"mice":[97],"were":[98],"response":[101],"AC480":[103],"(pan-HER":[104],"inhibitor,":[105],"\u201cHERi\u201d),":[106],"cediranib":[107],"(pan-VEGFR":[108],"inhibitor":[109,115],"\u201cVEGFRi\u201d),":[110],"BMS-690514":[112],"(combined":[113],"HER/VEGFR":[114],"\u201cEVRi\u201d).":[116],"EVRi":[117,148],"was":[118],"superior":[119],"HERi":[122],"VEGFRi":[124],"terms":[126],"tumor":[128,131,137],"growth,":[129],"final":[130],"weight,":[132],"progression-free":[134],"survival.":[135],"Correlative":[136],"studies":[138],"employing":[139],"phosphoproteomic":[140],"antibody":[141],"arrays":[142],"revealed":[143],"distinct":[144],"agent-specific":[145],"alterations,":[146],"inducing":[149],"greatest":[151],"effect":[153],"on":[154],"signaling.":[157],"These":[158],"data":[159],"suggest":[160],"simultaneous":[162],"inhibition":[163],"may":[168],"select":[170],"we":[179],"derived":[180],"a":[181],"novel":[182],"HER/VEGF":[183],"signature":[184],"correlated":[186],"poor":[188],"high-grade,":[192],"late":[193],"stage,":[194],"serous":[195],"patient":[198],"Mol":[200],"Cancer":[201],"Ther;":[202],"12(12);":[203],"2909\u201316.":[204],"\u00a92013":[205],"AACR.":[206]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2023-04-05T00:00:00"}